Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome

  title={Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome},
  author={V. Hamuryudan and C. Mat and S. Saip and Y. Ozyazgan and A. Siva and S. Yurdakul and K. Zwingenberger and H. Yazici},
  journal={Annals of Internal Medicine},
  • V. Hamuryudan, C. Mat, +5 authors H. Yazici
  • Published 1998
  • Medicine
  • Annals of Internal Medicine
  • The Behcet syndrome is a type of systemic vasculitis characterized by recurrent aphthous ulcers of the mouth and genitalia; various skin lesions; arthritis; and relapsing, sight-threatening panuveitis (Figure 1). Arteries and veins of all sizes, the central nervous system, and the gastrointestinal tract are involved, with serious consequences [1]. The course of the syndrome consists of exacerbations and remissions, and the severity generally diminishes with time. The syndrome occurs throughout… CONTINUE READING
    411 Citations
    Behcet Disease and the Emergence of Thalidomide
    • 31
    Mucocutaneous manifestations of Behçet's disease.
    • 18
    Gastrointestinal manifestations of Behcet's disease.
    • 65
    Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives
    • 20
    • PDF
    Infliximab as an alternative treatment for Behçet disease when other therapies fail.
    • 16
    Treatment of Behcets disease
    • 7
    Current Therapy for Behçet's Disease
    • 27
    Novel approaches to Behçet’s disease
    • 55
    Treatment of Behçet’s disease
    • 5
    • Highly Influenced


    Thalidomide in the treatment of Behçet's syndrome.
    • 93
    Thalidomide effects in Behçet's syndrome and pustular vasculitis.
    • 95
    Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis.
    • 103
    Other forms of vasculitis and pseudovasculitis.
    • 13
    Immunological studies on aphthous ulcer and erythema nodosum‐like eruptions in Behcet's disease
    • 104
    A controlled trial of azathioprine in Behçet's syndrome.
    • 269
    Gastrointestinal involvement in Behçet's syndrome: a controlled study.
    • 161
    • PDF